MSCLF

Satellos Bioscience Inc., a company dedicated to regenerative medicine, focuses on pioneering treatments for various degenerative muscle conditions. A cornerstone of their research is a leading program aimed at developing an orally administered drug. This therapeutic seeks to rectify muscle stem cell polarity, which in turn is intended to restore the body's natural processes for muscle repair and regeneration. The enterprise was founded in 2012 and operates from its primary offices located in Toronto, Canada.